KRAS and cancer: In TNBC and other cancers, the ID oncogenic transcripts foster diverse cancer-related events, including EMT, signaling (e.g., EGFR/TGF-beta [56,57,58,59,60,61], K-Ras, WNT, STAT3, PI3K/Akt, OCT-4/ID1/NF-kappaB), where ID genes are a target of many anticancer drugs, including vinblastine [62,63].